Lpl Financial LLC Alnylam Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 18,806 shares of ALNY stock, worth $4.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,806
Previous 18,636 0.91%
Holding current value
$4.61 Million
Previous $4.53 Million 14.24%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$233.81 - $287.01 $39,747 - $48,791
170 Added 0.91%
18,806 $5.17 Million
Q2 2024

Aug 07, 2024
BUY
$143.31 - $247.0 $238,181 - $410,514
1,662 Added 9.79%
18,636 $4.53 Million
Q1 2024

May 10, 2024
BUY
$146.51 - $198.2 $37,067 - $50,144
253 Added 1.51%
16,974 $2.54 Million
Q4 2023

Feb 14, 2024
BUY
$151.41 - $196.57 $143,990 - $186,938
951 Added 6.03%
16,721 $3.2 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $152,839 - $189,426
895 Added 6.02%
15,770 $2.79 Million
Q2 2023

Jul 31, 2023
BUY
$185.01 - $212.05 $30,526 - $34,988
165 Added 1.12%
14,875 $2.83 Million
Q1 2023

May 10, 2023
BUY
$182.66 - $235.53 $168,960 - $217,865
925 Added 6.71%
14,710 $2.95 Million
Q4 2022

Feb 07, 2023
BUY
$185.53 - $241.31 $101,484 - $131,996
547 Added 4.13%
13,785 $3.28 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $201,575 - $337,560
1,455 Added 12.35%
13,238 $2.65 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $581,026 - $816,824
-4,825 Reduced 29.05%
11,783 $1.72 Million
Q1 2022

May 16, 2022
BUY
$127.18 - $173.91 $90,806 - $124,171
714 Added 4.49%
16,608 $2.71 Million
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $445,491 - $584,337
2,792 Added 21.31%
15,894 $2.7 Million
Q3 2021

Nov 15, 2021
BUY
$169.75 - $207.73 $485,145 - $593,692
2,858 Added 27.9%
13,102 $2.47 Million
Q2 2021

Aug 13, 2021
BUY
$128.63 - $176.89 $147,024 - $202,185
1,143 Added 12.56%
10,244 $1.74 Million
Q1 2021

May 14, 2021
BUY
$126.83 - $175.69 $446,314 - $618,253
3,519 Added 63.04%
9,101 $1.29 Million
Q4 2020

Feb 12, 2021
SELL
$122.97 - $147.0 $12,051 - $14,406
-98 Reduced 1.73%
5,582 $725,000
Q3 2020

Nov 09, 2020
BUY
$121.19 - $165.49 $43,628 - $59,576
360 Added 6.77%
5,680 $827,000
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $60,129 - $90,265
577 Added 12.17%
5,320 $788,000
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $10,056 - $14,470
108 Added 2.33%
4,743 $516,000
Q4 2019

Feb 14, 2020
BUY
$74.51 - $124.23 $20,862 - $34,784
280 Added 6.43%
4,635 $534,000
Q3 2019

Nov 13, 2019
SELL
$70.9 - $87.82 $61,966 - $76,754
-874 Reduced 16.71%
4,355 $350,000
Q2 2019

Aug 09, 2019
BUY
$65.86 - $92.79 $56,442 - $79,521
857 Added 19.6%
5,229 $379,000
Q1 2019

May 08, 2019
BUY
$72.76 - $93.45 $96,843 - $124,381
1,331 Added 43.77%
4,372 $409,000
Q4 2018

Feb 07, 2019
SELL
$62.67 - $88.33 $55,901 - $78,790
-892 Reduced 22.68%
3,041 $222,000
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $15,403 - $21,589
176 Added 4.68%
3,933 $344,000
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $9,449 - $11,534
107 Added 2.93%
3,757 $370,000
Q1 2018

May 15, 2018
BUY
$115.92 - $148.54 $111,051 - $142,301
958 Added 35.59%
3,650 $435,000
Q4 2017

Feb 14, 2018
SELL
$114.49 - $139.98 $14,425 - $17,637
-126 Reduced 4.47%
2,692 $342,000
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $204,389 - $333,284
2,818
2,818 $331,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email